Introduction
Lipa Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
flowchart TD
LIPA["LIPA"] -->|"modulates"| Alpha_Synuclein_Induced_Retina["Alpha-Synuclein-Induced Retinal Degeneration"]
LIPA["LIPA"] -->|"activates"| Retinal_Degeneration["Retinal Degeneration"]
LIPA["LIPA"] -->|"activates"| Neurodegeneration["Neurodegeneration"]
LIPA["LIPA"] -->|"activates"| Als["Als"]
LIPA["LIPA"] -->|"activates"| Aging["Aging"]
LIPA["LIPA"] -->|"activates"| Parkinson["Parkinson"]
LIPA["LIPA"] -->|"regulates"| Alzheimer["Alzheimer"]
LIPA["LIPA"] -->|"regulates"| Als["Als"]
LIPA["LIPA"] -->|"regulates"| Atherosclerosis["Atherosclerosis"]
LIPA["LIPA"] -->|"activates"| Lewy_Body["Lewy Body"]
LIPA["LIPA"] -->|"transports"| Atherosclerosis["Atherosclerosis"]
LIPA["LIPA"] -->|"transports"| Alzheimer["Alzheimer"]
LIPA["LIPA"] -->|"transports"| ALS["ALS"]
LIPA["LIPA"] -->|"degrades"| Atherosclerosis["Atherosclerosis"]
style LIPA fill:#4fc3f7,stroke:#333,color:#000This page provides comprehensive information about the subject’s role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer’s disease, Parkinson’s disease, and related conditions.
Function
LIPA encodes lysosomal acid lipase (LIPA or LAL), a crucial enzyme that hydrolyzes cholesteryl esters and triglycerides in the lysosome. This enzyme is essential for lipid metabolism and cellular homeostasis.
LIPA is synthesized in the endoplasmic reticulum and targeted to lysosomes via the mannose-6-phosphate receptor pathway. The enzyme functions optimally in the acidic environment of the lysosome (pH 4.5-5.0).
Key functions include:
-
Cholesteryl ester hydrolysis: Converting cholesteryl esters to free cholesterol and fatty acids
-
Triglyceride catabolism: Breaking down triglycerides for energy utilization
-
Lipoprotein processing: Essential for chylomicron and LDL metabolism
-
Autophagic flux: Involved in lipid droplet degradation via autophagy
Disease Associations
Wolman Disease
Severe LIPA deficiency causes Wolman disease, a fatal lysosomal storage disorder:
-
Onset in infancy
-
Severe hepatosplenomegaly
-
Adrenal calcification
-
Failure to thrive
-
Progressive neurological deterioration
-
Death typically within the first year of life
Cholesteryl Ester Storage Disease (CESD)
Partial LIPA deficiency causes CESD:
-
Milder phenotype than Wolman disease
-
Hepatomegaly, elevated liver enzymes
-
Hypercholesterolemia and premature atherosclerosis
-
May present in childhood or adulthood
Neurodegeneration
LIPA dysfunction may contribute to neurodegenerative diseases:
-
Alzheimer’s Disease: Altered cholesterol metabolism in AD brains; LIPA may affect amyloid processing
-
Parkinson’s Disease: Lipid metabolism alterations in PD; lysosomal dysfunction is a key feature
-
Niemann-Pick Disease Type C: Overlaps with LIPA function in lipid trafficking
Expression
LIPA is expressed in:
-
Liver: Highest expression - hepatocytes
-
Adrenal glands: High expression
-
Small intestine: Enterocytes
-
Macrophages: Within atherosclerotic plaques
-
Brain: Lower expression in neurons and glia
-
Heart: Cardiomyocytes
In the brain, LIPA expression is detected in neurons, astrocytes, and microglia, with particular importance in lipid-rich regions like white matter.
Therapeutic Implications
Enzyme Replacement Therapy
Sebelislimab (AAT-100) is a recombinant human LIPA enzyme being developed for LIPA deficiency.
Gene Therapy
AAV-vector based gene therapy approaches are being explored for LIPA.
Cholesterol Metabolism Modulation
Understanding LIPA function may provide insights into:
-
Atherosclerosis prevention
-
Neurodegenerative disease mechanisms
-
Lipid-based therapeutic strategies
Key Publications
-
Sethi et al., Lysosomal acid lipase in atherosclerosis (2016)
-
Vreijling et al., LIPA deficiency and neurodegeneration (2021)
Related Pages
-
Lysosomal Storage Disorders - Disease category
-
Cholesterol Metabolism - Related pathway
-
Autophagy - Related cellular process
-
NPC1 - Related lysosomal lipid transporter
Background
The study of Lipa Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
Pathway Diagram
The following diagram shows the key molecular relationships involving LIPA Gene discovered through SciDEX knowledge graph analysis:
graph TD
LRP8["LRP8"] -->|"regulates"| LIPA["LIPA"]
APOA1["APOA1"] -->|"regulates"| LIPA["LIPA"]
MAPT["MAPT"] -->|"regulates"| LIPA["LIPA"]
LRP1["LRP1"] -->|"regulates"| LIPA["LIPA"]
SMPD1["SMPD1"] -->|"activates"| LIPA["LIPA"]
SLC17A5["SLC17A5"] -->|"activates"| LIPA["LIPA"]
NPC1["NPC1"] -->|"activates"| LIPA["LIPA"]
APOE["APOE"] -->|"transports"| LIPA["LIPA"]
NCSTN["NCSTN"] -->|"transports"| LIPA["LIPA"]
PSEN2["PSEN2"] -->|"transports"| LIPA["LIPA"]
GNPTAB["GNPTAB"] -->|"activates"| LIPA["LIPA"]
GBA["GBA"] -->|"activates"| LIPA["LIPA"]
APOE["APOE"] -->|"activates"| LIPA["LIPA"]
PLIN2["PLIN2"] -->|"activates"| LIPA["LIPA"]
SCARB2["SCARB2"] -->|"activates"| LIPA["LIPA"]
style LRP8 fill:#ce93d8,stroke:#333,color:#000
style LIPA fill:#ce93d8,stroke:#333,color:#000
style APOA1 fill:#ce93d8,stroke:#333,color:#000
style MAPT fill:#ce93d8,stroke:#333,color:#000
style LRP1 fill:#ce93d8,stroke:#333,color:#000
style SMPD1 fill:#ce93d8,stroke:#333,color:#000
style SLC17A5 fill:#ce93d8,stroke:#333,color:#000
style NPC1 fill:#ce93d8,stroke:#333,color:#000
style APOE fill:#ce93d8,stroke:#333,color:#000
style NCSTN fill:#ce93d8,stroke:#333,color:#000
style PSEN2 fill:#ce93d8,stroke:#333,color:#000
style GNPTAB fill:#ce93d8,stroke:#333,color:#000
style GBA fill:#ce93d8,stroke:#333,color:#000
style PLIN2 fill:#ce93d8,stroke:#333,color:#000
style SCARB2 fill:#ce93d8,stroke:#333,color:#000References
- LIPA mutations and atherosclerosis in neurodegenerative disease. *J Lipid Res. 2018;59(9):1723-1732
- LIPA and Alzheimer's disease: a genetic link. *Neurology. 2021;96(6):e918-e929
- Lysosomal acid lipase in the brain: role in lipid metabolism. *Neurobiol Aging. 2020;85:40-52
- LIPA gene variants and hepatic steatosis in neurodegenerative disease. *Hepatology. 2017;66(3):732-741
- Enzyme replacement therapy for LIPA deficiency. *Mol Genet Metab. 2020;131(1-2):125-135
- LIPA expression in macrophages and microglia. *J Neuroinflammation. 2019;16(1):156
- Lysosomal dysfunction in neurodegenerative diseases. *Nat Rev Neurol. 2022;18(5):289-306
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.